Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015401	pf-amyl	u/l (u/l)	322	405	0.00%
3015401	pf-amyl	— (—)	148	170	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of pleura

250

124

18.06

287.30

1.3

88.26

674.43

u/l

0.76

200

Pleural effusion

152

37.96

246.59

1.4

1.3

91.47

1176.33

u/l

0.52

128

Other pleural conditions

132

54.53

232.40

1.4

1.3

64.73

2035.58

u/l

0.53

113

Heart failure, not strict

177

159

7.70

106.30

1.3

1.2

264.77

272.21

u/l

0.01

121

125

Heart failure,strict

146

125

8.47

96.38

1.3

1.2

354.08

329.42

u/l

0.02

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

188

211

6.28

96.20

1.3

303.74

195.73

u/l

0.18

130

159

Pneumonias (Asthma/COPD co-morbidities)

187

211

6.15

93.40

1.3

305.57

195.73

u/l

0.19

129

159

All pneumoniae

185

210

6.09

91.42

1.3

307.89

196.66

u/l

0.19

128

158

Influenza and pneumonia

187

205

6.01

89.22

1.3

307.83

197.76

u/l

0.19

128

157

Bacterial pneumonia, not elsewhere classified

113

120

8.37

82.11

1.3

1.2

47.96

282.37

u/l

0.49

171

175

6.14

81.28

1.3

113.61

215.77

u/l

0.27

120

134

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

171

175

6.14

81.28

1.3

113.61

215.77

u/l

0.27

120

134

Bacterial pneumoniae

114

125

8.11

80.80

1.3

1.2

47.96

271.72

u/l

0.49

Heart failure, strict

157

187

6.07

78.78

1.3

1.2

339.63

233.56

u/l

0.13

147

Pneumonia, organism unspecified

161

201

5.81

77.73

1.3

339.66

202.31

u/l

0.22

117

153

All-cause Heart Failure

154

186

5.99

76.40

1.3

1.2

343.24

234.94

u/l

0.13

146

Other medical care

108

141

7.51

75.10

1.4

1.2

350.84

315.45

u/l

0.03

100

Other bacterial diseases

173

232

5.17

72.88

1.3

1.2

474.81

84.88

u/l

0.77

118

169

Heart failure and antihypertensive medication

14.65

64.54

1.3

1.2

46.15

1130.11

u/l

0.58

Implicit bacterial Sepsis

110

161

6.29

63.43

1.3

66.56

425.02

u/l

0.71

121

Bacterial Sepsis

118

178

5.92

63.35

1.3

63.56

398.35

u/l

0.73

132

Bacterial pneumonia (organism specified)

117

186

5.75

61.56

1.3

47.26

425.33

u/l

0.94

140

Dyspnoea

159

270

4.52

60.17

1.4

1.2

252.96

209.04

u/l

0.07

122

187

Persons encountering health services for specific procedures and health care

162

210

4.79

60.13

1.3

1.2

51.79

262.92

u/l

0.78

119

147

Bacterial infection, other or unspecified

113

185

5.53

56.90

1.4

1.2

374.55

66.90

u/l

0.50

129

Other heart diseases

12.22

56.80

1.3

26.91

150.02

u/l

0.76

Septicaemia

156

5.94

53.34

1.2

116.11

65.45

u/l

0.39

111

Other pulmonary diagnosis

8.28

52.39

1.2

1.3

131.31

616.89

u/l

0.40

COPD differential diagnosis

8.25

51.22

1.2

1.3

131.00

633.00

u/l

0.40

ILD differential diagnosis

8.25

51.22

1.2

1.3

131.00

633.00

u/l

0.40

Suppurative and necrotic conditions of lower respiratory tract

15.32

51.19

1.7

1.3

56.65

19.23

u/l

0.83

Excluding asthma or asthma-COPD overlap

8.11

50.67

1.2

1.3

131.00

616.89

u/l

0.40

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

141

5.81

48.88

1.3

81.24

273.36

u/l

0.38

Explicit Sepsis

167

5.47

48.46

1.2

1.3

117.54

415.81

u/l

0.57

126

Other septicaemia

151

5.74

47.61

1.2

121.75

59.22

u/l

0.47

107

Abnormalities of breathing

134

171

4.66

47.61

1.3

49.05

111.07

u/l

0.96

102

125

Asthma, unspecified (mode), excluding more controls

11.21

47.60

1.2

93.85

829.50

u/l

0.46

Renal tubulo-interstitial diseases

143

274

4.01

46.74

1.3

1.2

70.34

308.64

u/l

0.81

204

Pyothorax

16.65

46.22

1.7

1.3

60.06

16.44

u/l

0.80

COPD (mode)

10.31

45.48

1.2

1.3

56.12

858.07

u/l

0.49

Implicit Sepsis

126

228

4.30

45.32

1.2

1.3

85.73

326.44

u/l

0.64

170

Renal failure

108

216

4.59

44.33

1.4

1.2

76.10

354.72

u/l

0.74

164

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

8.91

43.64

1.3

110.87

568.03

u/l

0.39

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

7.35

43.45

1.3

121.75

453.41

u/l

0.36

Other heart diseases, wide

114

146

4.85

43.11

1.2

27.77

309.36

u/l

0.89

120

Non-ischemic cardiomyopathy

6.61

42.19

1.3

1.2

722.16

414.73

u/l

0.17

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

147

286

3.69

42.04

1.4

1.2

147.73

274.34

u/l

0.35

213

Asthma (only as main-diagnosis), excluding more controls

9.37

42.04

1.3

1.2

47.81

776.27

u/l

0.49

Care involving use of rehabilitation procedures

198

4.66

41.19

1.3

1.2

455.49

269.33

u/l

0.18

139

Asthma, unspecified (mode)

8.22

39.54

1.3

92.65

686.94

u/l

0.45

Asthma, excluding more controls

8.77

39.43

1.3

1.2

97.57

776.27

u/l

0.45

Heart failure and bmi 25plus

103

5.65

38.81

1.4

1.2

73.44

82.38

u/l

0.07

Asthma (mode)

7.08

38.16

1.3

91.79

633.00

u/l

0.44

Oxycodone

158

4.98

37.37

1.4

1.2

547.51

73.67

u/l

0.61

109

Valvular heart disease excluding rheumatic fever

102

5.60

36.74

1.5

1.2

47.80

385.21

u/l

0.70

Non-rheumatic valve diseases

102

5.60

36.68

1.5

1.2

47.80

385.21

u/l

0.70

Dialysis, with operation codes

8.46

36.45

1.6

1.1

35.55

536.61

u/l

0.49

Diseases of arteries, arterioles and capillaries (FINNGEN)

11.52

36.41

1.2

33.87

213.18

u/l

0.73

Atrial fibrillation and flutter

10.55

36.14

1.2

21.39

196.66

u/l

0.81

Atrial fibrillation and flutter with reimbursement

10.86

35.61

1.3

1.2

21.20

213.18

u/l

0.80

Condition for Implicit Sepsis (Organ dysfunction codes)

122

241

3.68

35.06

1.2

1.3

85.98

329.30

u/l

0.70

180

Asthma

6.64

34.47

1.3

93.33

633.00

u/l

0.44

Asthma (only as main-diagnosis)

6.76

33.63

1.3

47.81

633.00

u/l

0.49

Later onset COPD, excluding more controls

10.70

33.13

1.2

1.3

62.29

1297.53

u/l

0.46

Cardiac arrhythmias

5.38

32.14

1.2

1.3

23.12

78.86

u/l

0.87

Presence of cardiac and vascular implants and grafts

176

4.10

31.93

1.4

1.2

38.89

265.25

u/l

0.70

125

Chronic kidney disease

151

4.77

31.92

1.4

1.2

30.75

432.97

u/l

0.81

118

Erysipelas

198

4.06

31.13

1.4

1.2

819.22

63.73

u/l

0.79

141

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

8.64

30.78

1.3

1.2

725.71

164.28

u/l

0.37

Conduction disorders

6.28

30.58

1.3

1.2

27.62

429.78

u/l

0.59

Hypertensive diseases (excluding secondary)

7.86

30.24

1.2

149.93

149.21

u/l

0.00

GASTRO-related operations

4.80

30.05

1.4

1.2

469.07

28.75

u/l

0.71

Any gastric operation

4.80

30.05

1.4

1.2

469.07

28.75

u/l

0.71

COPD/asthma related infections

124

175

3.55

29.63

1.3

104.94

215.77

u/l

0.29

134

COPD/asthma/ILD related infections

124

175

3.55

29.63

1.3

104.94

215.77

u/l

0.29

134

Diseases of the respiratory system

5.94

29.52

1.3

1.2

79.83

604.82

u/l

0.45

Nephropathy related operations

7.22

29.22

1.6

1.2

29.16

570.34

u/l

0.57

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

107

295

3.37

29.04

1.4

1.3

71.11

298.87

u/l

0.78

206

Pacemaker

187

4.12

29.01

1.4

1.2

40.87

416.29

u/l

0.86

132

Other arrhythmias

129

4.46

28.18

1.2

65.08

318.73

u/l

0.64

105

Hypertension, essential

120

4.24

28.07

1.2

101.43

335.88

u/l

0.49

Acute renal failure

100

5.43

27.81

1.4

1.2

113.87

320.59

u/l

0.31

Hypertensive diseases

122

4.13

27.18

1.2

103.88

330.53

u/l

0.48

Hypertension

122

4.13

27.17

1.2

103.88

330.53

u/l

0.48

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

116

252

3.13

25.75

1.3

38.45

227.58

u/l

0.92

184

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

102

177

3.41

24.63

1.2

1.3

107.14

235.80

u/l

0.30

118

Malignant neoplasm, wide definition for exclusion

102

177

3.41

24.63

1.2

1.3

107.14

235.80

u/l

0.30

118

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

102

177

3.41

24.63

1.2

1.3

107.14

235.80

u/l

0.30

118

Abnormal findings on diagnostic imaging of lung

249

3.37

23.76

1.2

1.3

78.91

350.36

u/l

0.78

173

AV-block

6.79

23.57

1.2

1.1

21.68

605.40

u/l

0.60

Oral corticosteroids

131

282

2.81

23.46

1.3

1.2

306.83

90.08

u/l

0.44

198

Implicit viral Sepsis

6.08

23.24

1.4

1.3

85.68

463.51

u/l

0.42

Viral Sepsis

6.08

23.24

1.4

1.3

85.68

463.51

u/l

0.42

Early onset COPD, excluding more controls

9.05

22.92

1.2

1.4

37.91

1093.05

u/l

0.50

Aplastic and other anaemias

227

3.39

22.46

1.4

1.3

49.83

360.39

u/l

0.91

167

Cardiomyopathy

6.96

22.44

1.3

1.2

59.29

716.90

u/l

0.65

Care involving dialysis

9.36

21.75

1.8

1.1

42.00

1297.37

u/l

0.55

Metabolic disorders

118

263

2.79

21.05

1.3

358.62

74.29

u/l

0.57

194

Haemorrhage from respiratory passages

118

4.26

20.53

1.4

1.3

49.68

122.82

u/l

0.75

Asthma-related pneumonia

175

3.66

20.23

1.3

1.2

95.79

266.62

u/l

0.42

118

Asthma-related pneumonia or sepsis

175

3.66

20.23

1.3

1.2

95.79

266.62

u/l

0.42

118

Asthma, hospital admissions 3, pneumonia

175

3.66

20.23

1.3

1.2

95.79

266.62

u/l

0.42

118

Any event in cancer register

101

200

3.00

20.11

1.2

1.3

111.18

206.56

u/l

0.25

138

Certain infectious and parasitic diseases

103

168

3.07

20.11

1.3

1.2

422.96

70.20

u/l

0.62

129

Primary_lymphoid and hematopoietic malignant neoplasms

5.01

19.90

1.3

29.50

414.97

u/l

0.49

Cardiovascular diseases (excluding rheumatic etc)

5.78

19.76

1.3

797.12

132.07

u/l

0.49

Extracorporeal dialysis

9.67

19.68

1.8

1.1

44.60

1154.53

u/l

—

Inflammatory bowel disease treatment related agents

129

284

2.58

19.44

1.3

1.2

554.20

89.74

u/l

0.72

199

Malignant neoplasm

200

2.94

19.10

1.2

1.3

112.57

208.39

u/l

0.24

136

First line medication for Crohn's disease

119

243

2.67

18.92

1.3

1.2

289.28

98.59

u/l

0.34

171

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

6.06

18.55

1.3

40.72

663.09

u/l

0.48

Respiratory insufficiency

14.20

18.44

1.2

1.5

106.25

3110.57

u/l

—

Bleeding

109

301

2.64

18.38

1.3

453.63

175.59

u/l

0.35

218

Heart failure and coronary heart disease

154

3.40

18.27

1.4

1.3

31.27

500.77

u/l

0.90

109

Other and unspecified anaemias

216

3.19

18.02

1.4

1.3

52.88

351.26

u/l

0.80

159

Malignant neoplasm of respiratory system and intrathoracic organs

113

4.09

18.01

1.2

156.04

354.91

u/l

0.29

ILD medications: prednisolone, methylprednisolone, prednisone

121

267

2.56

17.98

1.3

1.2

605.96

91.08

u/l

0.70

193

Other anaemias

216

3.18

17.93

1.4

1.3

52.88

351.26

u/l

0.80

159

All influenza

5.23

17.91

1.3

1.2

189.86

419.12

u/l

0.25

Infections, IBD-co-morbidities

7.56

17.83

1.4

1.0

1231.48

41.14

u/l

0.47

Acute tubulo-interstitial nephritis

230

3.01

17.64

1.3

47.17

339.92

u/l

0.87

172

ILD medications: immunosuppressive drugs

217

3.14

17.59

1.3

1.2

548.37

104.20

u/l

0.40

154

ILD medications

122

267

2.51

17.27

1.3

1.2

592.59

91.08

u/l

0.69

193

Cerebrovascular diseases (FINNGEN)

6.73

17.22

1.5

1.2

274.43

182.11

u/l

0.19

Diseases of arteries, arterioles and capillaries

279

2.65

17.02

1.3

469.44

185.54

u/l

0.31

202

Iron deficiency anaemia secondary to blood loss (chronic)

5.09

16.91

1.5

1.3

150.05

495.28

u/l

0.37

Paroxysmal tachycardia

8.13

16.76

1.2

26.57

212.98

u/l

0.71

Complications of surgical and medical care, not elsewhere classified

113

330

2.46

16.54

1.4

1.2

378.26

179.31

u/l

0.26

238

Fever of other and unknown origin

213

3.05

16.40

1.3

571.81

238.23

u/l

0.26

155

Complications of medical and surgical care

328

2.61

15.89

1.5

1.2

484.69

163.02

u/l

0.34

239

Other disorders of fluid, electrolyte and acid-base balance

133

3.63

15.58

1.3

1.2

228.90

98.48

u/l

0.61

Other chronic obstructive pulmonary disease

204

2.94

15.42

1.2

1.3

51.78

400.05

u/l

0.87

145

Symptoms and signs involving the circulatory and respiratory systems

172

2.74

15.31

1.2

1.3

395.14

110.50

u/l

0.41

126

Pain in throat and chest

170

2.88

15.15

1.3

478.23

111.78

u/l

0.45

124

Any reimbursement code in KELA

5.82

14.87

1.4

1.2

806.15

29.23

u/l

0.49

Iron deficiency anaemia

196

3.09

14.85

1.3

106.31

393.32

u/l

0.60

140

COPD

212

2.85

14.74

1.2

1.3

51.84

385.90

u/l

0.87

151

Polyarthropathies

207

2.71

14.65

1.2

867.61

117.43

u/l

0.68

150

Glomerular disorders in diseases classified elsewhere

5.30

14.64

1.4

1.2

62.83

591.00

u/l

0.46

Hypertensive heart and/or renal disease

4.47

14.55

1.1

1.2

1060.64

487.85

u/l

0.22

Type 2 diabetes, wide definition

237

2.56

14.49

1.3

41.90

69.56

u/l

0.54

173

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

288

2.67

14.40

1.5

1.2

554.26

180.36

u/l

0.35

206

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

4.30

14.25

1.3

39.77

421.49

u/l

0.47

Cardiomyopathies, Primary/intrinsic

6.18

14.18

1.3

1.2

87.08

801.25

u/l

0.52

Disorders of lipoprotein metabolism and other lipidaemias

253

2.46

14.13

1.3

357.26

74.73

u/l

0.44

185

General examination and investigation of persons without complaint and reported diagnosis

125

3.03

13.98

1.3

550.29

73.18

u/l

0.44

Codeine

215

2.51

13.95

1.3

1.2

723.97

59.70

u/l

0.78

157

Complications of procedures, not elsewhere classified

321

2.45

13.93

1.4

1.2

444.66

183.88

u/l

0.29

230

Peripheral artery disease

222

2.72

13.93

1.3

71.29

206.26

u/l

0.49

164

Transplanted organ and tissue status

6.25

13.73

1.5

1.2

1606.81

929.82

u/l

0.15

COPD, hospital admission 2, with asthma infections

160

3.10

13.72

1.2

1.3

53.56

472.99

u/l

0.79

112

Glomerular diseases

4.08

13.70

1.4

1.2

1214.36

397.34

u/l

0.30

Other diseases of the respiratory system

109

3.77

13.65

1.2

1.3

215.58

343.63

u/l

0.17

Other respiratory disorders and diseases

109

3.77

13.65

1.2

1.3

215.58

343.63

u/l

0.17

Other special examinations and investigations of persons without complaint or reported diagnosis

125

2.96

13.62

1.2

1.3

501.56

73.18

u/l

0.53

Parasetamol

138

2.85

13.55

1.2

1.3

546.08

59.20

u/l

0.74

Nutritional anaemias

240

2.76

13.55

1.3

96.60

342.72

u/l

0.64

174

COPD, hospital admissions

229

2.70

13.53

1.2

1.3

51.41

354.76

u/l

0.86

164

Cardiomyopathy (excluding other)

5.87

13.51

1.3

1.1

87.08

777.18

u/l

0.52

Insulin medication

247

2.63

13.45

1.4

1.3

111.57

227.19

u/l

0.34

180

COPD, early/later onset

231

2.67

13.24

1.2

1.3

51.41

352.73

u/l

0.85

165

Cardiovascular diseases

4.91

13.24

1.3

968.81

118.05

u/l

0.50

Atherosclerosis, excluding cerebral and coronary sclerosis

213

2.71

13.21

1.2

1.3

58.93

193.32

u/l

0.46

156

Other CVD (FINNGEN)

8.33

13.03

1.1

1.2

31.90

236.23

u/l

—

Venous thromboembolism

279

2.58

12.92

1.4

1.2

581.86

172.04

u/l

0.41

198

Disorders of gallbladder, biliary tract and pancreas

110

317

2.24

12.87

1.2

1.3

731.89

62.28

u/l

0.96

226

Other chronic obstructive pulmonary disease, including avohilmo

265

2.51

12.83

1.2

1.3

54.72

326.07

u/l

0.88

187

Asthma, hospital admission 2, infections

256

2.65

12.81

1.3

89.58

351.14

u/l

0.75

179

Asthma-related infections

256

2.65

12.81

1.3

89.58

351.14

u/l

0.75

179

Type 2 diabetes

101

257

2.34

12.73

1.2

1.3

383.15

84.96

u/l

0.49

188

Intestinal infectious diseases

328

2.30

12.69

1.3

454.25

176.11

u/l

0.31

237

COPD, hospital admissions 3, with asthma pneumonia sepsis

141

3.14

12.61

1.2

1.3

53.92

527.43

u/l

0.80

100

Hypo-osmolality and hyponatraemia

4.37

12.53

1.5

1.2

224.53

81.65

u/l

0.42

Other bacterial intestinal infections

4.14

12.47

1.3

1.2

1040.44

426.39

u/l

0.24

Enterocolitis due to Clostridium difficile

5.23

12.47

1.4

1.1

23.33

736.59

u/l

0.57

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

5.23

12.47

1.1

1.3

32.58

749.10

u/l

0.48

General symptoms and signs

108

237

2.29

12.37

1.3

40.71

223.50

u/l

0.81

174

Benign neoplasm of colon, rectum, anus and anal canal

135

3.02

12.35

1.5

1.2

610.59

307.40

u/l

0.20

Neoplasms

113

2.99

12.26

1.3

1.2

97.45

388.48

u/l

0.47

Other diseases of pancreas

6.04

12.12

1.2

3226.06

29.65

u/l

0.89

Diabetes, varying definitions

100

262

2.28

12.03

1.3

381.22

83.92

u/l

0.48

193

Diabetes mellitus

100

262

2.28

11.99

1.3

381.22

83.92

u/l

0.48

193

DVT of lower extremities and pulmonary embolism

226

2.70

11.73

1.3

1.2

691.31

193.46

u/l

0.41

156

Peripheral arterial reconstruction

107

3.56

11.69

1.3

1.2

31.95

363.63

u/l

0.57

COPD-related respiratory insufficiency

4.47

11.65

1.0

1.3

26.84

639.55

u/l

0.58

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.02

11.61

1.3

1.2

920.96

169.20

u/l

0.38

Osteopathies and chondropathies

237

2.60

11.57

1.4

1.3

62.69

214.01

u/l

0.60

171

Diseases of oesophagus, stomach and duodenum

108

305

2.15

11.40

1.3

704.92

82.34

u/l

0.79

223

Hard cardiovascular diseases

262

2.28

11.40

1.3

104.21

184.89

u/l

0.28

191

COPD related to multimorbidity

200

2.66

11.36

1.2

1.3

53.02

384.68

u/l

0.78

140

Primary_lymphoid and hematopoietic malignant neoplasms

129

3.26

11.31

1.3

29.50

302.68

u/l

0.58

Insulin, intermediate and long-acting

278

2.47

11.29

1.4

1.3

120.09

307.77

u/l

0.54

203

Chronic lower respiratory diseases

116

298

2.11

11.27

1.2

1.3

69.37

307.89

u/l

0.85

211

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.14

11.25

1.4

1.2

1480.78

745.20

u/l

0.19

Covid-19 confirmed case

115

3.40

11.19

1.3

25.62

330.53

u/l

0.60

Presence of other devices

106

3.50

11.09

1.4

1.2

875.50

365.12

u/l

0.24

Pure hypercholesterolaemia

245

2.33

11.08

1.3

847.59

76.60

u/l

0.76

177

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

143

2.89

10.99

1.3

54.60

268.05

u/l

0.45

Non-allergic asthma (mode), excluding more controls

7.83

10.87

1.2

35.78

1692.46

u/l

—

Codeine or tramadol medication

115

307

2.08

10.85

1.3

631.31

91.66

u/l

0.72

224

Insulin, combination of fast acting with intermediate-acting or long-acting

300

2.34

10.74

1.4

1.3

111.57

293.52

u/l

0.57

218

Bacterial intestinal infections, IBD co-morbidities

3.73

10.55

1.3

1.2

1040.44

420.27

u/l

0.25

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

261

2.20

10.53

1.3

430.19

83.77

u/l

0.51

192

Chronic periapical parodontitis

101

3.47

10.41

1.3

32.81

119.70

u/l

0.95

Factors influencing health status and contact with health services

4.46

10.33

1.3

854.89

135.77

u/l

0.40

Diabetes medication

282

2.14

10.30

1.3

408.78

203.25

u/l

0.26

206

Other diseases of pericardium

18.90

10.26

1.5

1.3

39.60

3062.13

u/l

—

Endocrine, nutritional and metabolic diseases

143

2.53

10.16

1.3

515.77

65.91

u/l

0.61

107

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

4.80

10.00

1.2

1643.50

802.04

u/l

0.20

Diarrhoea and gastroenteritis of presumed infectious origin

261

2.37

9.91

1.3

651.72

208.02

u/l

0.33

190

Autoimmune diseases excluding thyroid diseases

105

282

2.07

9.86

1.2

1.3

386.10

198.53

u/l

0.23

210

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.10

9.84

1.4

1.0

383.75

33.59

u/l

0.60

GI-bleeding

180

2.73

9.71

1.4

1.3

999.58

244.55

u/l

0.43

131

Other disorders of skin and subcutaneous tissue

313

2.23

9.63

1.4

1.2

44.53

285.07

u/l

0.99

229

Unspecified acute lower respiratory infection

3.92

9.56

1.1

1.3

111.07

542.79

u/l

0.49

Diabetes, insulin treatment (Kela reimbursement)

293

2.07

9.56

1.3

1.2

419.59

78.17

u/l

0.52

217

Implicit fungal Sepsis

10.08

9.55

1.6

1.1

25.80

17.17

u/l

—

STROKE

164

2.54

9.53

1.4

1.3

180.97

67.87

u/l

0.52

126

Antihypertensive medication - note that there are other indications

3.65

9.52

1.3

32.18

662.26

u/l

0.62

Autoimmune diseases excluding thyroid diseases, strict definition

100

269

2.07

9.48

1.2

1.3

391.81

205.60

u/l

0.22

201

Ischaemic heart disease, wide definition

248

2.17

9.44

1.4

1.3

40.86

359.44

u/l

1.01

175

Abnormalities of heart beat

102

3.31

9.40

1.3

76.45

124.85

u/l

0.29

Type 2 diabetes, strict (exclude DM1)

261

2.11

9.26

1.2

1.3

392.14

84.35

u/l

0.49

190

Type 2 diabetes, definitions combined

257

2.11

9.25

1.2

1.3

396.86

84.96

u/l

0.49

188

Major coronary heart disease event excluding revascularizations

270

2.15

9.22

1.3

42.78

334.20

u/l

1.02

193

Ischemic heart diseases

251

2.15

9.20

1.4

1.3

40.61

355.57

u/l

1.01

177

Fall on same level

106

296

2.00

9.20

1.3

1.2

443.02

183.96

u/l

0.32

216

Abnormal findings on examination of blood, without diagnosis

250

2.36

9.19

1.3

26.39

333.40

u/l

1.06

188

Provisional assignment of new diseases of uncertain etiology

176

2.67

9.00

1.3

1.2

27.03

260.99

u/l

0.76

129

Codes for special purposes

176

2.67

9.00

1.3

1.2

27.03

260.99

u/l

0.76

129

ILD, hospital admissions 3, with pneumonia sepsis

5.51

8.97

1.4

1.2

417.36

1075.00

u/l

0.26

Major coronary heart disease event

277

2.10

8.92

1.3

40.38

326.28

u/l

1.03

198

Insulin, fast-acting

177

2.66

8.90

1.3

1.2

137.69

266.51

u/l

0.29

127

ILD, hospital admission 2, with pulmonary infections

5.16

8.88

1.3

1.2

417.36

873.97

u/l

0.21

Non-allergic asthma (mode)

6.20

8.87

1.2

1.4

35.78

1300.06

u/l

—

Disorders of lens

225

2.19

8.77

1.3

43.37

209.31

u/l

0.71

174

Osteoporosis

112

3.07

8.76

1.6

1.2

81.04

351.35

u/l

0.48

Coronary atherosclerosis

235

2.17

8.75

1.3

41.32

376.15

u/l

1.00

165

Acute pancreatitis

3.42

8.74

1.3

1.2

1313.50

82.69

u/l

0.65

Other diseases of the digestive system

179

2.63

8.73

1.5

1.3

1035.72

243.15

u/l

0.42

132

Angina pectoris

226

2.21

8.70

1.3

46.39

388.09

u/l

0.97

159

Hypertensive Heart Disease

3.60

8.65

1.2

1308.75

487.85

u/l

0.26

Persons encountering health services for examination and investigation

125

2.49

8.63

1.2

1.3

599.23

73.18

u/l

0.61

Nausea and vomiting

3.25

8.60

1.2

72.00

48.30

u/l

0.20

Nonischemic cardiomyopathy

6.40

8.53

1.4

1.1

30.57

54.19

u/l

—

Other (not insulin) diabetes medications

277

2.03

8.52

1.2

1.3

427.03

194.01

u/l

0.29

201

Diseases of the digestive system

241

2.36

8.47

1.4

1.3

863.36

200.93

u/l

0.44

174

Asthma (diagnoses ohter than nonallergic)

347

2.05

8.45

1.3

84.50

271.32

u/l

0.71

243

Insulin, fast-acting or short human

184

2.56

8.27

1.3

1.2

137.69

253.04

u/l

0.27

134

L04AX Other immunosuppressants

234

2.35

8.12

1.2

1.3

635.12

226.88

u/l

0.29

173

Other acute lower respiratory infections

235

2.32

8.06

1.3

82.90

226.66

u/l

0.53

166

Asthma/COPD (KELA code 203)

297

2.02

8.03

1.3

91.48

309.29

u/l

0.72

210

Type 2 diabetes, definitions combined, including avohilmo

258

2.02

8.01

1.2

1.3

415.15

85.06

u/l

0.49

187

Fungal Sepsis

7.91

7.99

1.6

1.1

25.80

16.88

u/l

—

Genitourinary diseases

118

2.47

7.97

1.3

1.2

692.26

66.82

u/l

0.65

Senile cataract

219

2.13

7.87

1.4

1.3

51.33

214.75

u/l

0.66

169

Malaise and fatigue

185

2.39

7.82

1.2

1.3

90.62

243.09

u/l

0.46

139

Benign neoplasm: Colon

137

2.58

7.77

1.6

1.2

759.49

296.44

u/l

0.26

Pulmonary heart disease, diseases of pulmonary circulation

167

2.58

7.72

1.4

1.3

160.83

233.35

u/l

0.14

121

Myocardial infarction

203

2.23

7.70

1.3

45.18

423.68

u/l

0.94

140

Diseases of pulp and periapical tissues

156

2.63

7.67

1.3

57.97

122.60

u/l

0.68

117

Valvular operations

4.33

7.67

1.3

1.1

29.29

716.56

u/l

0.58

Second line medication for Crohn's disease

241

2.28

7.62

1.2

1.3

635.12

224.32

u/l

0.29

177

Infections of the skin and subcutaneous tissue

247

2.26

7.56

1.4

1.3

132.66

335.14

u/l

0.50

177

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

320

1.91

7.55

1.4

1.2

835.87

79.05

u/l

0.76

236

Biguanides

290

1.93

7.46

1.3

441.81

188.85

u/l

0.31

207

Sequelae of external causes of morbidity and mortality

115

2.88

7.30

1.4

1.3

75.10

324.44

u/l

0.46

Use of hypnotics and sedatives

306

1.87

7.27

1.3

95.34

287.81

u/l

0.65

223

Diabetic nephropathy, excluding more controls

3.40

7.21

1.3

64.00

587.52

u/l

0.51

Explicit bacterial Sepsis

4.49

7.17

1.2

38.70

810.39

u/l

—

Pulmonary embolism

156

2.57

7.15

1.4

1.2

169.03

250.49

u/l

0.15

112

Pulmonary heart disease

156

2.57

7.15

1.4

1.2

169.03

250.49

u/l

0.15

112

COPD, hospital admissions 1, only main diagnosis

182

2.34

7.13

1.2

1.3

55.74

424.58

u/l

0.78

126

Symptoms and signs involving the digestive system and abdomen

243

1.92

7.09

1.4

1.3

462.50

75.06

u/l

0.58

176

Glucagon-like peptide-1 (GLP-1) analogues

256

2.09

7.02

1.3

74.79

210.82

u/l

0.46

181

Coronary revascularization (ANGIO or CABG)

187

2.20

7.00

1.2

1.3

45.05

450.31

u/l

0.92

129

Amputation

3.86

6.97

1.5

1.2

38.42

674.44

u/l

0.49

Peripheral artery operations in Hilmo

3.39

6.95

1.5

1.2

38.21

529.14

u/l

0.56

Acute pancreatitis (for exclusion)

102

2.95

6.94

1.3

1313.50

82.51

u/l

0.65

Streptococcal septicaemia

4.59

6.92

1.3

1.2

38.70

29.71

u/l

—

Later onset COPD

145

2.44

6.90

1.2

1.3

60.15

538.43

u/l

0.79

Other and unspecified iron deficiency

148

2.57

6.82

1.3

1.2

29.29

274.80

u/l

0.61

104

Gastrointestinal diseases

2.46

6.60

1.4

1.3

685.33

51.47

u/l

0.54

L04AD Calcineurin inhibitors

4.34

6.48

1.7

1.4

24.56

834.74

u/l

—

Opioids

216

1.95

6.46

1.2

532.16

59.70

u/l

0.66

157

Oedema, not elsewhere classified

124

2.65

6.31

1.3

1246.29

340.47

u/l

0.33

Tramadol

210

2.02

6.24

1.3

1.2

137.73

60.71

u/l

0.64

152

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

290

2.04

6.20

1.5

1.2

71.87

306.33

u/l

0.81

206

Nerve, nerve root and plexus disorders

345

1.77

6.13

1.3

499.70

158.42

u/l

0.41

252

Amputation of toe

4.12

6.08

1.5

1.2

41.30

723.52

u/l

—

295

1.77

6.08

1.2

1.3

441.59

180.33

u/l

0.28

217

Symptoms and signs involving the urinary system

322

1.85

5.89

1.4

1.3

518.05

174.49

u/l

0.33

229

Seropositive rheumatoid arthritis

118

2.62

5.84

1.2

1.3

23.52

78.63

u/l

1.05

Unspecified kidney failure

3.79

5.81

1.1

1.0

28.56

786.07

u/l

—

Reimbursement for rheumatic diseases

270

2.03

5.80

1.3

53.26

196.50

u/l

0.65

191

Shoulder lesions

250

1.86

5.67

1.2

532.56

193.76

u/l

0.31

179

Gout

153

2.33

5.63

1.3

1.2

1088.88

102.86

u/l

0.44

105

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

4.07

5.62

1.5

1.2

19.43

991.32

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

121

2.57

5.60

1.2

1.3

23.52

311.48

u/l

0.60

Pain in limb

259

1.90

5.59

1.4

1.3

659.98

192.00

u/l

0.43

186

Malignant neoplasm of urinary organs

3.40

5.58

1.2

2014.92

631.25

u/l

0.30

DVT of lower extremities

2.80

5.55

1.3

1.2

1822.73

72.91

u/l

0.50

Presbycusis

3.17

5.53

1.6

1.1

95.77

588.59

u/l

0.49

Calcific aortic valvular stenosis

198

2.18

5.53

1.4

1.2

57.66

399.20

u/l

0.79

138

Calcific aortic valvular stenosis, operated

198

2.18

5.53

1.4

1.2

57.66

399.20

u/l

0.79

138

Calcific aortic valvular stenosis, diagnosis (helper)

198

2.18

5.53

1.4

1.2

57.66

399.20

u/l

0.79

138

Operations 2 for CAVS

198

2.18

5.53

1.4

1.2

57.66

399.20

u/l

0.79

138

Other/unspecified seropositive rheumatoid arthritis

122

2.54

5.52

1.2

1.3

23.52

308.42

u/l

0.60

Seropositive rheumatoid arthritis, wide

122

2.54

5.52

1.2

1.3

23.52

308.42

u/l

0.60

Calcific aortic valvular stenosis, including rheumatic fever

198

2.18

5.51

1.4

1.2

57.66

399.20

u/l

0.79

138

Dentinal caries

2.72

5.45

1.6

1.3

25.50

122.00

u/l

1.07

Supplementary factors related to causes of morbidity and mortality classified elsewhere

123

2.52

5.43

1.5

1.3

320.35

329.44

u/l

0.01

Syncope and collapse

185

2.16

5.43

1.3

84.85

246.08

u/l

0.48

137

All influenza (not pneumonia)

3.73

5.36

1.1

1.2

145.80

620.60

u/l

—

Bronchitis

352

1.71

5.35

1.2

1.3

69.61

266.09

u/l

0.86

258

Abnormal serum enzyme levels

190

2.19

5.34

1.2

1.3

28.52

428.35

u/l

1.00

138

Rheumatoid arthritis

140

2.34

5.28

1.2

1.3

797.68

105.60

u/l

0.42

102

Polyneuropathies and other disorders of the peripheral nervous system

119

2.53

5.27

1.2

1.3

178.44

324.97

u/l

0.21

Hypokalaemia

3.86

5.25

1.1

1.3

262.30

127.08

u/l

—

Gout, FINNGEN

175

2.23

5.23

1.3

1088.88

88.34

u/l

0.45

122

Cardiac arrest

5.76

5.21

1.1

1.2

23.60

293.90

u/l

—

Other retinal disorders

292

1.84

5.17

1.2

1.3

39.98

300.44

u/l

1.00

212

Sequelae with surgical and medical care as external cause

2.69

5.16

1.4

1.3

94.27

382.59

u/l

0.43

Coronary angioplasty

173

2.09

5.10

1.2

1.3

27.58

477.98

u/l

0.98

121

Abdominal and pelvic pain

243

1.76

5.10

1.5

1.3

861.63

75.06

u/l

0.87

176

Cutaneous abscess, furuncle and carbuncle

104

2.60

5.04

1.4

1.3

209.75

408.03

u/l

0.27

Misadventures to patients during surgical and medical care

3.17

5.03

1.7

1.3

1976.46

589.64

u/l

0.30

Diabetic nephropathy

103

2.59

5.00

1.3

61.94

700.14

u/l

0.80

Asthma, hospital admissions , main diagnosis only

338

1.80

4.99

1.4

1.3

47.37

290.50

u/l

1.04

235

Emergency coronary revascularization (for ACS)

268

1.82

4.98

1.3

46.17

327.71

u/l

0.93

188

External causes of morbidity and mortality

140

2.01

4.95

1.3

1.2

604.67

97.59

u/l

0.48

107

Type of accident

111

2.53

4.94

1.5

1.3

361.52

351.78

u/l

0.01

Neurological diseases, wide definition

3.25

4.92

1.1

1290.59

42.00

u/l

0.47

Hernia of abdominal wall, postoperative

3.48

4.88

1.7

1.1

261.00

28.00

u/l

0.47

Myocardial infarction, strict

192

1.98

4.86

1.2

51.25

447.63

u/l

0.92

132

Type 1 diabetes, wide definition, subgroup 1

2.99

4.81

1.3

1.2

20.56

111.15

u/l

—

Dental caries

112

2.48

4.76

1.5

1.3

25.43

145.93

u/l

1.36

Cerebrovascular diseases

314

1.74

4.74

1.3

741.26

153.27

u/l

0.48

233

Other soft tissue disorders, not elsewhere classified

264

1.76

4.72

1.4

1.3

638.19

189.40

u/l

0.43

189

Gastroduodenal ulcer

138

2.32

4.71

1.2

25.81

58.37

u/l

0.70

103

Falls/tendency to fall

256

1.70

4.69

1.3

1.2

442.62

92.20

u/l

0.48

186

Other diseases of intestines

296

1.69

4.68

1.3

92.91

293.31

u/l

0.67

224

Benign neoplasm: Rectum

3.02

4.66

1.4

1.2

46.86

542.76

u/l

0.47

Benign neoplasm: Rectum, anus and anal canal

2.84

4.64

1.4

1.2

45.81

479.01

u/l

0.47

Early onset COPD

115

2.44

4.61

1.2

1.3

37.91

351.66

u/l

0.65

Diseases of liver

161

2.18

4.47

1.6

1.2

206.04

257.85

u/l

0.08

115

Disorders of choroid and retina

332

1.69

4.41

1.2

1.3

54.43

273.03

u/l

0.92

242

Sensorineural hearing loss

303

1.71

4.40

1.2

1.3

32.07

293.30

u/l

1.07

222

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.82

4.38

1.2

1.3

43.40

482.36

u/l

0.54

Hernia

325

1.67

4.34

1.3

141.19

273.02

u/l

0.39

232

Intracranial trauma

154

2.04

4.32

1.3

1.2

174.64

64.89

u/l

0.46

116

Neurological diseases

200

1.76

4.30

1.3

509.82

89.10

u/l

0.47

144

Pain (limb, back, neck, head abdominally)

177

1.81

4.29

1.3

1.2

623.41

58.32

u/l

0.64

125

Type 1 diabetes

2.58

4.28

1.3

1.2

66.73

154.70

u/l

0.55

Finngen Rheumatological endpoints

246

1.72

4.27

1.2

1.3

451.06

109.78

u/l

0.38

179

L04AA Selective immunosuppressants

2.56

4.20

1.5

1.3

30.69

439.94

u/l

0.67

Other disorders of teeth and supporting structures

102

2.45

4.20

1.5

1.3

37.72

109.74

u/l

0.73

171

2.09

4.18

1.3

1.2

47.18

271.64

u/l

0.66

122

Used for control exclusion in common control thyroid runs

262

1.65

4.12

1.3

453.83

209.98

u/l

0.27

196

Spinal stenosis

232

1.83

4.10

1.1

1.3

727.29

222.61

u/l

0.34

165

Fracture of lower leg, including ankle

249

1.88

4.08

1.4

1.3

121.98

206.19

u/l

0.26

182

Cough

123

2.26

4.07

1.4

1.3

1532.65

122.79

u/l

0.45

Myocardial infarction, without ST-elevation

244

1.85

4.03

1.3

32.15

348.61

u/l

1.00

175

Conductive and sensorineural hearing loss

308

1.66

4.01

1.2

1.3

32.06

289.28

u/l

1.08

226

Injury, poisoning and certain other consequences of external causes

120

1.96

4.00

1.3

1.2

700.11

109.22

u/l

0.48

162

2.03

3.90

1.1

1.3

33.12

262.21

u/l

0.59

108

Infective dermatitis

2.89

3.89

1.2

1.3

94.50

557.48

u/l

0.47

Other gastritis (incl. Duodenitis)

106

2.36

3.89

1.2

32.47

65.40

u/l

0.49

Adjustment and management of implanted device

2.64

3.89

1.1

1.2

24.60

493.14

u/l

0.57

Type 1 diabetes, wide definition

2.63

3.88

1.3

1.2

20.56

150.35

u/l

—

Asthma, including avohilmo

349

1.57

3.87

1.3

437.87

169.86

u/l

0.33

246

Other specified/unspecified arthritis

119

2.27

3.86

1.1

1.3

40.39

124.74

u/l

1.03

Acute bronchitis

188

1.98

3.85

1.4

1.3

86.76

252.80

u/l

0.47

131

Obesity related asthma

152

2.11

3.82

1.4

1.3

28.30

282.08

u/l

0.74

116

Cholelithiasis, broad definition with cholecystitis

304

1.65

3.81

1.2

1.3

466.23

58.03

u/l

0.49

218

Injuries to the knee and lower leg

345

1.56

3.81

1.3

453.47

167.74

u/l

0.34

248

Rheumatoid arthritis, including avohilmo

186

1.99

3.81

1.2

1.3

772.24

66.59

u/l

0.45

130

Glomerulonephritis

3.07

3.80

1.3

3663.71

677.97

u/l

—

Other respiratory diseases principally affecting the interstitium

108

2.32

3.75

1.3

1.2

357.92

361.45

u/l

0.00

Other arthritis (FG)

134

2.17

3.72

1.1

1.3

38.48

119.47

u/l

1.16

104

Colorectal cancer, excluding all cancers (controls excluding all cancers)

105

2.30

3.68

1.4

1.2

32.29

362.29

u/l

0.49

Statin medication

165

1.80

3.64

1.2

1.3

29.03

296.22

u/l

0.90

128

Diseases of the musculoskeletal system and connective tissue

100

2.01

3.64

1.1

1.2

702.78

89.01

u/l

0.43

Injuries to the head

359

1.56

3.61

1.3

482.56

174.09

u/l

0.35

264

Benign neoplasms

123

1.93

3.57

1.2

41.34

365.03

u/l

0.61

Autoimmune diseases

283

1.57

3.57

1.3

469.38

197.68

u/l

0.30

211

Cellulitis

2.35

3.56

1.2

1.3

67.89

435.44

u/l

0.62

Medical observation and evaluation for suspected diseases and conditions

125

1.89

3.56

1.4

1.3

647.31

73.18

u/l

0.44

Other disorders of kidney and ureter

2.61

3.46

1.0

1.3

3203.75

500.92

u/l

—

118

2.17

3.45

1.1

1.2

35.59

357.88

u/l

0.58

Unstable angina pectoris

200

1.83

3.43

1.4

1.3

35.18

413.48

u/l

0.97

143

Sequelae of injuries, of poisoning and of other consequences of external causes

100

2.30

3.42

1.3

103.48

398.22

u/l

0.50

Phlebitis and thrombophlebitis (not including DVT)

2.34

3.40

1.5

1.3

1527.53

118.87

u/l

0.46

Symptoms and signs involving cognition, perception, emotional state and behaviour

349

1.57

3.40

1.2

1.3

522.49

175.34

u/l

0.32

256

Other and unspecified polyneuropathies, also in other diseases

107

2.25

3.37

1.3

195.63

325.91

u/l

0.16

Gastro-oesophageal reflux disease

288

1.69

3.37

1.4

1.3

110.47

81.65

u/l

0.15

209

Benign neoplasm of colon, rectum, anus and anal canal

328

1.65

3.37

1.5

1.2

577.00

172.62

u/l

0.33

232

Unspecified haematuria

215

1.79

3.35

1.3

931.73

222.58

u/l

0.38

154

Benign neoplasm: Colon, unspecified

2.43

3.34

1.8

1.2

1837.58

441.24

u/l

0.33

Other disorders of ear

323

1.57

3.30

1.3

31.67

277.24

u/l

1.08

237

Cholelithiasis

297

1.61

3.29

1.2

1.3

53.54

58.73

u/l

0.08

213

Alcohol use disorder, Swedish definition

272

1.71

3.20

1.2

1.3

719.39

204.52

u/l

0.41

192

Diabetic retinopathy, excluding more controls

2.16

3.19

1.3

1.2

23.33

533.21

u/l

0.57

Fracture of rib(s), sternum and thoracic spine

157

1.98

3.18

1.2

1.3

88.43

292.39

u/l

0.49

109

Fracture of lumbar spine and pelvis

110

2.18

3.17

1.5

1.3

86.25

363.61

u/l

0.46

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.47

3.12

1.2

1.3

36.00

479.79

u/l

0.48

Mycoses

118

2.12

3.09

1.6

1.2

28.25

351.88

u/l

0.69

Disorders of thyroid, IBD co-morbidities

3.24

3.08

1.1

1.0

22.86

36.95

u/l

—

Other functional intestinal disorders

213

1.79

3.04

1.2

1.3

61.28

363.06

u/l

0.82

160

Dermatitis

299

1.67

3.03

1.3

1.2

56.58

295.14

u/l

0.85

210

Deviated nasal septum

167

1.92

3.02

1.4

1.3

75.43

488.13

u/l

0.81

117

Coronary artery bypass grafting

131

1.92

2.99

1.2

1.3

71.57

575.25

u/l

0.79

Other dorsopathies, not elsewhere classified

264

1.54

2.98

1.3

515.52

215.60

u/l

0.27

189

Diseases of male genital organs

151

1.71

2.94

1.3

1.2

212.05

268.09

u/l

0.09

114

Episodal and paroxysmal disorders

290

1.50

2.94

1.3

466.68

84.83

u/l

0.49

209

Stroke, including SAH

289

1.59

2.94

1.3

1.2

900.46

164.17

u/l

0.49

215

Functional dyspepsia

101

2.18

2.92

1.1

1.2

3020.19

68.64

u/l

0.79

Symptoms and signs involving the nervous and musculoskeletal systems

280

1.68

2.90

1.2

1.3

56.20

325.31

u/l

0.91

195

Other CVD

108

2.13

2.89

1.1

1.3

29.29

367.18

u/l

0.59

Gastric ulcer

2.25

2.86

1.0

1.2

22.00

75.32

u/l

0.71

Diseases of the eye and adnexa

182

1.62

2.83

1.4

1.3

589.86

86.54

u/l

0.53

144

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2.15

2.83

1.3

1.2

34.79

560.94

u/l

0.51

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2.15

2.83

1.3

1.2

34.79

560.94

u/l

0.51

Spondylopathies

252

1.57

2.82

1.1

1.3

600.69

209.25

u/l

0.30

180

Other symptoms and signs involving the nervous and musculoskeletal systems

193

1.81

2.82

1.2

1.3

66.95

238.93

u/l

0.55

142

Polycystic ovarian syndrome, consortium definition

126

1.82

2.82

1.2

1.3

973.50

87.45

u/l

0.47

Rotator cuff syndrome

242

1.63

2.79

1.2

1.3

65.20

200.55

u/l

0.53

172

Dorsalgia

263

1.52

2.79

1.3

504.72

215.60

u/l

0.25

189

Other embolism and thrombosis

2.47

2.78

1.4

1.3

27.56

85.67

u/l

—

Benign neoplasm of other and ill-defined parts of digestive system

2.55

2.78

1.1

1.2

3276.38

581.61

u/l

—

Abnormal results of function studies

3.23

2.77

1.3

1.4

16.00

989.08

u/l

—

Injuries to the thorax

239

1.72

2.75

1.4

1.3

79.00

372.60

u/l

0.76

158

Impingement syndrome of shoulder

124

2.02

2.75

1.2

1.3

1483.17

314.50

u/l

0.37

Hypotension

2.20

2.72

1.1

1.3

30.45

432.51

u/l

0.58

Other nutritional deficiencies

250

1.68

2.68

1.3

77.47

337.49

u/l

0.78

183

Other cataract

179

1.73

2.67

1.2

45.63

237.47

u/l

0.66

142

Ulcer of lower limb, not elsewhere classified

2.28

2.67

1.6

1.3

44.08

450.46

u/l

0.54

Malignant neoplasm of digestive organs

238

1.70

2.65

1.2

1.3

66.77

348.63

u/l

0.79

170

Gonarthrosis [arthrosis of knee](FG)

234

1.56

2.65

1.3

576.53

95.35

u/l

0.42

170

Noninfective enteritis and colitis

205

1.75

2.63

1.3

35.14

239.43

u/l

0.80

154

Other intervertebral disc disorders

259

1.54

2.62

1.3

678.19

219.53

u/l

0.34

185

Accidents

202

1.56

2.62

1.3

554.98

88.45

u/l

0.48

147

Tuberculosis

2.90

2.58

1.1

32.17

768.41

u/l

—

Constipation

347

1.49

2.57

1.2

1.3

82.13

257.72

u/l

0.72

255

ILD, hospital admissions

2.19

2.56

1.3

1.2

383.75

429.05

u/l

0.04

Gout, strict definition

114

2.02

2.55

1.3

1.2

29.14

338.06

u/l

0.58

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

128

1.95

2.54

1.2

1.3

38.19

321.55

u/l

0.66

Varicose veins

253

1.58

2.54

1.4

1.2

47.14

74.35

u/l

0.48

184

281

1.60

2.54

1.2

1.3

738.03

197.36

u/l

0.43

200

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

140

1.76

2.52

1.2

1.3

177.30

270.10

u/l

0.14

Soft tissue disorders

267

1.48

2.50

1.2

1.3

147.78

188.61

u/l

0.11

190

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

2.27

2.50

1.5

1.3

30.00

489.19

u/l

0.49

Interstitial lung disease endpoints

2.14

2.44

1.3

1.2

383.75

415.80

u/l

0.03

Interstitial lung disease

2.14

2.44

1.3

1.2

383.75

415.80

u/l

0.03

Other external causes of accidental injury

202

1.54

2.43

1.3

566.89

88.45

u/l

0.49

147

Disorders of other endocrine glands

178

1.77

2.42

1.1

1.2

61.99

264.53

u/l

0.62

130

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

5.02

2.40

1.2

1.0

4280.83

22.86

u/l

—

Stroke, excluding SAH

282

1.53

2.40

1.3

954.66

167.05

u/l

0.48

210

Intestinal stricture

167

1.80

2.39

1.3

1.2

28.48

267.73

u/l

0.70

118

Other interstitial pulmonary diseases

2.11

2.38

1.3

1.2

383.75

415.80

u/l

0.03

Injuries to the ankle and foot

241

1.63

2.38

1.2

1.3

1773.75

90.14

u/l

0.80

179

286

1.57

2.37

1.2

1.3

719.39

194.13

u/l

0.43

204

Other diseases of anus and rectum

139

1.87

2.35

1.5

1.2

206.63

535.95

u/l

0.41

100

L01XE Protein kinase inhibitors

3.22

2.30

1.4

1.2

3246.00

1232.10

u/l

—

Ischaemic Stroke, excluding all haemorrhages

278

1.52

2.30

1.3

956.00

173.01

u/l

0.45

208

Gout, idiopatic and unspecified

155

1.81

2.29

1.3

1439.06

277.39

u/l

0.37

113

Retention of urine

174

1.70

2.28

1.1

1.2

74.58

256.27

u/l

0.52

128

Diseases of the skin and subcutaneous tissue

260

1.45

2.24

1.3

1.2

69.45

315.74

u/l

0.79

193

Hyperlipidaemia, other/unspecified

197

1.68

2.23

1.1

1.2

1058.38

81.13

u/l

0.45

140

Other skin changes

2.10

2.22

1.2

1.3

24.27

437.93

u/l

0.59

Cholecystectomy

324

1.50

2.18

1.1

1.3

59.90

277.79

u/l

0.88

235

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.13

2.18

1.7

1.3

36.33

433.10

u/l

0.56

Diabetic retinopathy, strict definition

1.96

2.15

1.4

1.3

21.50

374.54

u/l

—

Obesity due to excess calories

181

1.71

2.14

1.3

92.52

247.36

u/l

0.45

136

Dorsopathies

264

1.43

2.11

1.2

1.3

40.12

215.60

u/l

0.85

189

Gonarthrosis

204

1.52

2.11

1.3

1.2

639.81

99.56

u/l

0.42

149

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

139

1.69

2.10

1.2

1.3

145.23

272.89

u/l

0.20

Low back pain

259

1.52

2.09

1.3

769.23

218.49

u/l

0.34

186

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

139

1.68

2.08

1.2

1.3

145.23

272.89

u/l

0.20

Examination and observation for other reasons

122

1.69

2.08

1.1

1.3

1092.13

73.71

u/l

0.46

Concussion

151

1.72

2.06

1.1

1.2

171.60

64.78

u/l

0.35

113

Hyperplasia of prostate

141

1.62

2.04

1.4

1.2

37.85

288.64

u/l

0.52

105

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

155

1.63

2.02

1.2

1.3

183.00

256.79

u/l

0.12

102

Dental operations

192

1.50

2.02

1.3

649.44

61.33

u/l

0.53

134

Other diseases of blood and blood-forming organs, wide

111

1.89

2.00

1.3

322.67

335.61

u/l

0.01

Chronic gastritis

140

1.79

2.00

1.4

1.2

26.82

61.15

u/l

0.70

Other disorders of urethra and urinary system

273

1.48

2.00

1.3

1.2

618.95

191.98

u/l

0.33

195

Viral and other specified intestinal infections

2.50

1.99

1.5

1.2

176.32

718.40

u/l

—

Procreative management

1.98

1.99

1.2

1.4

33.04

448.91

u/l

0.67

Benign neoplasms

275

1.42

1.98

1.3

38.67

218.92

u/l

0.93

194

Sleep apnoea

337

1.41

1.96

1.4

1.3

959.74

79.24

u/l

0.81

238

Anterior Iridocyclitis

1.98

1.94

1.4

1.3

169.92

378.38

u/l

0.28

Iridocyclitis

1.94

1.4

1.2

158.79

412.41

u/l

0.38

Injuries to the abdomen, lower back, lumbar spine and pelvis

193

1.65

1.94

1.4

1.3

1230.36

249.55

u/l

0.39

135

Degeneration of macula and posterior pole

250

1.52

1.94

1.2

1.3

47.00

318.24

u/l

0.84

181

Cardiodefibrillation

233

1.59

1.93

1.4

1.3

52.42

365.64

u/l

0.87

162

Sleep disorders (combined)

343

1.40

1.93

1.3

958.98

78.37

u/l

0.81

243

Redundant prepuce, phimosis and paraphimosis

2.02

1.93

1.1

1.2

215.60

450.32

u/l

—

ILD, hospital admissions 1, main diag only

2.05

1.90

1.3

1.2

23.22

473.27

u/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

2.03

1.89

1.3

1.2

33.25

603.04

u/l

0.51

Sub-endpoint used in defining T1D endpoints

133

1.78

1.89

1.3

1.2

62.83

363.51

u/l

0.69

Umbilical hernia

128

1.80

1.89

1.4

1.3

44.81

584.53

u/l

0.88

In situ neoplasms

108

1.86

1.88

1.1

1.2

77.47

336.94

u/l

0.39

Amiodarone users

2.16

1.88

1.1

1.2

21.67

493.92

u/l

—

Unspecified fall

234

1.57

1.86

1.3

831.42

79.69

u/l

0.47

163

Sulfonylureas

187

1.58

1.85

1.2

58.80

253.42

u/l

0.51

135

Wet age-related macular degeneration

1.91

1.85

1.2

25.54

434.00

u/l

0.61

Paralytic ileus and intestinal obstruction

122

1.80

1.83

1.4

1.2

27.38

584.06

u/l

0.87

Complications of internal orthopaedic prosthetic devices, implants and grafts

115

1.83

1.82

1.4

1.2

1714.33

326.70

u/l

0.37

Benign neoplasm: Rectum

101

1.88

1.80

1.4

1.3

46.86

369.85

u/l

0.54

Sleep apnoea, including avohilmo

339

1.38

1.80

1.4

1.3

926.89

79.11

u/l

0.81

239

Convulsions, not elsewhere classified

2.00

1.79

1.4

1.3

30.55

493.26

u/l

0.71

Disorders of sclera, cornea, iris and ciliary body

248

1.53

1.75

1.4

1.2

1072.08

210.39

u/l

0.41

182

Acute and subacute iridocyclitis

1.98

1.74

1.3

1.2

197.09

418.52

u/l

0.27

Systemic connective tissue disorders

162

1.67

1.74

1.1

1.2

1587.93

61.82

u/l

0.47

116

Benign neoplasm: Rectum, anus and anal canal

117

1.80

1.73

1.4

1.2

45.81

331.63

u/l

0.54

Obesity

246

1.53

1.73

1.4

1.3

82.03

335.58

u/l

0.76

184

Obesity and other hyperalimentation

246

1.53

1.73

1.4

1.3

82.03

335.58

u/l

0.76

184

Cervical disc disorders

178

1.63

1.72

1.2

1340.75

278.88

u/l

0.38

124

Diabetic retinopathy

145

1.57

1.70

1.3

25.11

521.16

u/l

0.96

108

Chronic periodontitis

2.00

1.69

1.3

12.50

146.55

u/l

—

Other hearing loss

153

1.67

1.69

1.5

1.2

79.35

493.88

u/l

0.73

108

Other noninfective gastroenteritis and colitis

104

1.83

1.66

1.1

1.3

31.64

338.48

u/l

0.57

Coxarthrosis [arthrosis of hip](FG)

215

1.48

1.66

1.3

780.32

100.55

u/l

0.43

156

Disorders of parathyroid gland

103

1.82

1.65

1.1

1.3

77.66

362.94

u/l

0.49

Hyperparathyroidism

1.89

1.64

1.1

1.3

91.09

413.09

u/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.98

1.64

1.1

1.3

38.20

484.69

u/l

—

Fracture of foot, except ankle

1.87

1.60

1.2

1.3

168.20

66.38

u/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1.70

1.59

1.3

1.4

31.50

42.34

u/l

0.36

Dizziness and giddiness

326

1.39

1.58

1.2

1.3

697.45

170.02

u/l

0.36

238

Other arthrosis

192

1.49

1.57

1.5

1.2

956.24

105.45

u/l

0.47

138

Status post-ami

2.35

1.57

2.0

1.1

27.80

45.35

u/l

—

Transport accidents

162

1.59

1.55

1.2

1.3

23.68

89.85

u/l

1.33

114

Other neurological diseases

345

1.38

1.55

1.3

29.54

267.02

u/l

1.12

251

Unspecified urinary incontinence

2.43

1.53

1.3

1.4

37.63

1037.58

u/l

—

Excessive, frequent and irregular menstruation

1.75

1.52

1.2

1.4

1648.27

78.17

u/l

0.53

Alcohol use disorder, ICD-based

217

1.52

1.50

1.2

1.3

175.84

379.13

u/l

0.39

155

Benign neoplasm: Colon

317

1.42

1.50

1.6

1.2

759.49

168.27

u/l

0.37

227

Mental and behavioural disorders due to alcohol, excluding acute intoxication

233

1.50

1.2

1.3

165.30

362.17

u/l

0.41

166

Leisure time condition

1.90

1.49

1.3

276.09

409.14

u/l

—

Inguinal hernia

234

1.41

1.47

1.4

1.3

111.49

347.82

u/l

0.58

170

Epilepsy

139

1.65

1.46

1.1

1.2

26.18

75.88

u/l

0.82

103

Glaucoma suspect

195

1.54

1.45

1.3

21.44

220.81

u/l

0.67

137

Viral infections characterized by skin and mucous membrane lesions

171

1.58

1.45

1.3

231.76

240.17

u/l

0.01

125

Other abnormal uterine and vaginal bleeding

1.87

1.44

1.3

1.4

136.33

86.87

u/l

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

3.13

1.44

2.2

1.3

214.80

3654.83

u/l

—

Haemorrhoids and perianal venous thrombosis

148

1.62

1.43

1.2

32.25

483.30

u/l

0.86

110

Arthropathies

215

1.37

1.41

1.2

526.21

114.54

u/l

0.39

156

Dermatitis and eczema

370

1.31

1.41

1.4

1.3

79.37

257.68

u/l

0.78

267

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

248

1.46

1.41

1.5

1.3

79.55

362.95

u/l

0.85

177

Ulcerative rectosigmoiditis

2.42

1.39

1.3

29.14

959.35

u/l

—

Seropositive rheumatoid arthritis, strict definition

1.89

1.38

1.4

1.3

27.38

477.52

u/l

—

Thyrotoxicosis

1.77

1.38

1.2

1.3

25.09

375.75

u/l

0.58

Sarcoidosis

2.00

1.38

1.6

1.3

284.00

536.03

u/l

0.19

Leiomyoma of uterus

1.73

1.37

1.3

1.2

35.69

611.86

u/l

0.52

Renal cell carcinoma of kidney

2.62

1.37

1.2

1.1

4280.83

18.00

u/l

—

Transient ischemic attack

274

1.39

1.33

1.3

33.46

170.15

u/l

0.70

206

Substance abuse, excluding more controls

253

1.42

1.33

1.2

1.3

147.06

323.48

u/l

0.41

182

Diagnoses used for exclusion with ILD

136

1.62

1.32

1.4

1.3

205.94

301.00

u/l

0.14

Thyrotoxicosis, other and/or unspecified

1.84

1.29

1.3

27.75

415.57

u/l

—

Exposure to unspecified factor

378

1.31

1.29

1.3

131.33

246.50

u/l

0.39

271

Artificial opening status

2.78

1.28

1.6

1.1

26.60

1825.50

u/l

—

Fracture at wrist and hand level

145

1.59

1.28

1.2

1.3

254.42

312.59

u/l

0.07

104

Other antidepressants

316

1.29

1.28

1.4

1.2

93.40

298.59

u/l

0.70

220

Intracranial injury

283

1.40

1.27

1.3

181.67

196.04

u/l

0.03

207

Presence of other functional implants

194

1.42

1.26

1.3

1.2

67.50

252.42

u/l

0.59

137

Disorders of lacrimal system

194

1.50

1.26

1.1

1.3

1545.65

81.07

u/l

0.47

139

Other diseases of stomach and duodenum

2.40

1.24

1.7

1.2

22.17

183.12

u/l

—

Diaphragmatic hernia

195

1.49

1.23

1.3

83.90

413.76

u/l

0.71

134

Hernia of abdominal wall

237

1.44

1.22

1.4

1.3

146.07

344.17

u/l

0.41

166

Prepatellar bursitis

2.64

1.21

1.0

1.4

27.40

1574.71

u/l

—

Acute upper respiratory infections

351

1.29

1.21

1.3

577.69

175.81

u/l

0.33

255

Other diseases of upper respiratory tract

333

1.27

1.20

1.3

52.19

287.03

u/l

1.00

238

Malignant neoplasm of breast, HER2-negative

131

1.51

1.20

1.2

1.3

34.80

341.46

u/l

0.66

Autoimmune diseases related-to ILD

366

1.32

1.20

1.3

55.94

246.92

u/l

0.88

268

Memory loss

2.00

1.16

1.2

196.20

687.00

u/l

—

Other contact dermatitis

0.00

1.16

0.0

1.4

—

988.16

—

Other neurotic disorders

2.50

1.15

1.6

1.3

30.20

1561.64

u/l

—

Substance abuse

287

1.37

1.12

1.2

1.3

147.06

301.65

u/l

0.39

206

Disorders of eyelid, lacrimal system and orbit

357

1.30

1.12

1.1

1.3

1296.83

73.09

u/l

0.78

262

Lumbar disc prolapse

245

1.36

1.11

1.5

1.3

933.40

231.30

u/l

0.38

174

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1.55

1.10

1.3

1.4

32.00

42.34

u/l

0.33

Malignant neoplasm of breast

132

1.48

1.08

1.2

1.3

34.80

337.72

u/l

0.66

Artificial joint operation, meniscal resection

357

1.27

1.07

1.3

602.50

168.49

u/l

0.38

256

Erectile dysfunction

1.87

1.07

1.4

1.2

32.00

33.73

u/l

—

Gout, unspecified

129

1.55

1.05

1.3

32.31

291.80

u/l

0.57

Cystitis

279

0.72

1.04

1.2

62.56

188.77

u/l

0.48

199

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.27

1.03

1.0

1.3

22.20

1696.15

u/l

—

Benign neoplasm of bone and articular cartilage

2.27

1.03

1.0

1.3

29.02

1472.07

u/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

177

1.46

1.03

1.2

1.3

173.76

239.34

u/l

0.14

133

Combinations of oral blood glucose lowering drugs

154

1.49

1.03

1.3

87.13

310.49

u/l

0.45

110

Congenital malformations, deformations and chromosomal abnormalities

211

1.41

1.03

1.5

1.2

65.60

241.50

u/l

0.62

154

Colorectal adenocarcinoma

114

1.58

1.02

1.2

36.00

339.46

u/l

0.56

Inflammatory bowel disease

130

1.54

1.02

1.4

1.3

39.21

355.47

u/l

0.79

Benign neoplasm of other and ill-defined parts of digestive system

1.65

1.00

1.1

1.3

3276.38

407.16

u/l

—

Other systemic involvement of connective tissue

123

1.55

0.99

1.2

2203.80

61.16

u/l

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.97

0.0

1.2

—

1118.14

—

Fracture of forearm

226

1.37

0.94

1.3

1025.56

90.74

u/l

0.48

162

Arthrosis

207

1.30

0.94

1.3

1.2

35.53

117.29

u/l

1.58

151

Postmenopausal atrophic vaginitis

0.48

0.93

1.4

531.80

64.79

u/l

—

Mental and behavioural disorders due to psychoactive substance use

294

1.32

0.92

1.2

1.3

147.06

295.09

u/l

0.38

211

Thyrotoxicosis with toxic multinodular goitre

2.15

0.91

1.5

1.2

28.33

1444.47

u/l

—

Fall on same level involving ice and snow

278

1.33

0.91

1.3

35.04

314.42

u/l

1.01

200

Benzodiazepine use

379

1.24

0.91

1.3

36.94

262.58

u/l

1.15

271

Other enthesopathies

126

1.51

0.91

1.8

1.3

48.65

312.72

u/l

0.60

Dental caries 2

248

0.70

0.91

1.1

1.3

28.56

219.05

u/l

0.94

185

Sciatica+with lumbago

207

1.38

0.90

1.4

1.2

59.27

243.60

u/l

0.64

146

Injuries to the elbow and forearm

283

1.31

0.89

1.3

820.03

92.32

u/l

0.47

202

Keratitis

143

1.47

0.89

1.2

1955.21

307.84

u/l

0.42

105

Use of disulfiram, acamprosate or naltrexone

2.07

0.89

1.0

1.4

475.00

1071.63

u/l

—

Urticaria and erythema

135

1.48

0.88

1.3

29.33

306.64

u/l

0.69

101

N06DA Anticholinesterases

177

0.64

0.88

1.1

1.2

48.00

247.08

u/l

—

117

Use of anticholinesterases

177

0.64

0.88

1.1

1.2

48.00

247.08

u/l

—

117

Diabetic neuropathy

1.68

0.87

1.1

1.3

22.40

520.90

u/l

—

Open wound of head

259

1.33

0.87

1.2

1.3

901.52

213.02

u/l

0.36

185

Myocardial infarction, unclassifiable

136

1.44

0.85

1.2

28.67

293.07

u/l

0.58

Coxarthrosis

196

1.32

0.83

1.3

1.2

879.63

103.06

u/l

0.44

143

Visual disturbances and blindness

257

1.32

0.82

1.4

1.3

213.24

319.89

u/l

0.20

185

Benign neoplasm: Skin of other and unspecified parts of face

1.88

0.81

1.5

1.3

32.00

1166.42

u/l

—

Glaucoma

295

1.28

0.81

1.3

40.14

296.85

u/l

0.97

212

Diseases of pulp and periapical tissues, including avohilmo

322

1.21

0.81

1.2

1.3

439.70

197.20

u/l

0.26

224

Other disorders of lacrimal gland

155

1.42

0.80

1.1

1.3

1747.27

61.08

u/l

0.48

118

Dental caries 2 and operation codes

244

0.72

0.80

1.1

1.3

28.56

221.23

u/l

0.94

183

Melanocytic naevi of other and unspecified parts of face

0.00

0.79

0.0

1.1

—

1371.75

—

Fall on and from stairs and steps

114

1.49

0.79

1.3

1.2

142.17

321.72

u/l

0.30

Use of selegiline

0.00

0.79

0.0

1.1

—

18.06

—

Other and unspecified dermatitis

242

1.32

0.78

1.4

1.3

33.80

349.25

u/l

0.98

173

Fracture of skull and facial bones

1.56

0.78

1.3

135.79

118.76

u/l

—

Lower back pain or/and sciatica

378

1.21

0.76

1.3

592.89

166.73

u/l

0.35

274

Carpal tunnel syndrome

251

1.29

0.76

1.3

1118.88

194.32

u/l

0.45

179

Sequelae of cerebrovascular disease

198

1.33

0.75

1.2

1.3

81.38

201.65

u/l

0.36

148

254

1.30

0.75

1.3

34.76

320.79

u/l

0.89

178

Conjunctivitis (acute, non atopic)

107

1.49

0.75

1.5

1.2

2079.36

111.81

u/l

0.47

Benign neoplasm of bone and articular cartilage

2.08

0.74

1.0

1.1

29.02

1370.56

u/l

—

Visual disturbances

227

1.32

0.74

1.4

1.3

232.32

344.31

u/l

0.19

167

Other systemic involvement of connective tissue (FG)

107

1.49

0.74

1.1

1.3

2446.11

84.60

u/l

—

Disorders of refraction and accommodation

1.53

0.74

1.4

1.3

204.00

429.57

u/l

—

Mental and behavioural disorders due to alcohol

264

1.29

0.73

1.2

1.3

165.30

324.20

u/l

0.35

188

Dental pulpitis 1

322

1.19

0.72

1.2

1.3

447.17

197.19

u/l

0.26

224

Dental pulpitis 4

322

1.19

0.72

1.2

1.3

447.17

197.19

u/l

0.26

224

Meniscus derangement

197

1.29

0.72

1.3

1.2

1019.20

102.59

u/l

0.45

143

Traumatic subdural haemorrhage

1.67

0.71

1.8

1.2

208.00

57.56

u/l

—

Radiculopathy

1.55

0.71

1.1

1.3

27.16

423.23

u/l

—

Unspecified mental disorder

160

1.38

0.70

1.1

1.3

25.30

304.13

u/l

0.85

118

Seborrhoeic keratosis

118

1.44

0.69

1.4

1.2

51.22

303.02

u/l

—

Actinic keratosis

236

1.29

0.67

1.3

35.95

339.96

u/l

0.87

164

Diseases of oral cavity, salivary glands and jaws

269

1.20

0.67

1.2

1.3

576.46

101.72

u/l

0.43

188

Benign lipomatous neoplasm of other sites/unspecified

1.79

0.66

1.2

1.3

31.82

1382.06

u/l

—

Dislocation, sprain and strain of joints and ligaments of knee

215

1.30

0.66

1.3

92.95

217.07

u/l

0.42

165

Benign neoplasm: Colon, unspecified

146

1.37

0.63

1.8

1.2

1837.58

269.55

u/l

0.39

102

severe traumatic brain injury, does not include concussion

129

1.40

0.63

1.5

1.2

114.40

301.75

u/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

290

1.23

0.62

1.2

1.3

142.13

266.98

u/l

0.31

212

Other diseases of urinary system

324

1.18

0.62

1.4

1.3

488.56

188.64

u/l

0.30

231

Voice disturbances

121

1.41

0.62

1.4

1.3

119.30

307.93

u/l

—

Disorders of synovium and tendon

211

1.28

0.61

1.5

1.3

170.10

217.48

u/l

0.09

147

Carcinoma in situ of skin of trunk

0.00

0.60

0.0

1.1

—

18.57

—

Oral lichen ruber planus, including avohilmo

0.00

0.60

0.0

1.3

—

2220.09

—

Fibromyalgia

0.00

0.60

0.0

1.3

—

1886.15

—

Other intracranial haemorrhages

0.00

0.60

0.0

1.1

—

20.63

—

Other disorders of bone

1.50

0.59

1.4

1.3

29.22

475.71

u/l

—

Other specific joint derangements/joint disorders

205

1.24

0.59

1.3

1.2

73.61

119.01

u/l

0.47

148

Progressive vascular leukoencephalopathy

0.00

0.59

0.0

1.1

—

19.36

—

Other noninflammatory disorders of vagina

0.00

0.59

0.0

1.4

—

30.69

—

Acute sinusitis

195

1.29

0.59

1.3

53.29

252.04

u/l

0.72

149

Alzheimer’s disease, wide definition

125

0.67

0.56

1.0

1.2

35.40

331.69

u/l

—

Colorectal cancer

141

1.35

0.56

1.2

34.38

284.37

u/l

0.57

Chronic diseases of tonsils and adenoids

224

0.79

0.55

1.3

53.75

230.02

u/l

0.70

165

Degenerative diseases of the nervous system

173

0.74

0.55

1.1

1.2

36.67

247.57

u/l

—

117

Benign neoplasm: Transverse colon

1.62

0.55

1.8

1.3

37.83

928.96

u/l

—

Benign neoplasm: Caecum

1.62

0.55

1.3

42.00

1011.19

u/l

—

Pain in joint

163

1.26

0.55

1.3

1.2

82.81

60.32

u/l

0.25

113

Skin changes due to chronic exposure to nonionizing radiation

243

1.25

0.54

1.3

35.95

333.20

u/l

0.87

168

Diseases of the ear and mastoid process

305

1.16

0.54

1.3

444.49

93.30

u/l

0.40

225

Acute upper respiratory infections of multiple and unspecified sites

260

1.21

0.54

1.3

44.81

212.60

u/l

0.82

192

Exclusions for E4_PCOS_CONSORTIUM

166

1.25

0.53

1.2

1.3

34.04

247.43

u/l

0.64

123

Malignant neoplasm of skin

311

1.19

0.52

1.2

1.3

134.19

269.36

u/l

0.37

224

Unspecific neurodegenerative disorder

202

0.78

0.50

1.0

1.3

39.08

400.78

u/l

0.86

137

Menorrhagia

1.36

0.50

1.1

1.4

27.30

79.13

u/l

—

Injuries to the hip and thigh

247

1.22

0.49

1.3

61.15

348.53

u/l

0.84

173

Delivery

0.71

0.48

1.3

3475.43

62.06

u/l

—

Neurotic, stress-related and somatoform disorders

270

1.18

0.48

1.3

33.26

205.86

u/l

0.91

199

D07AA Corticosteroids, weak (group I)

1.46

0.46

1.6

1.3

23.29

679.49

u/l

—

Malignant neoplasm of breast, HER-positive

127

1.32

0.46

1.3

33.25

339.09

u/l

0.64

Symptoms and signs involving the skin and subcutaneous tissue

345

1.18

0.45

1.2

1.3

57.80

268.72

u/l

0.87

243

Anxiety disorders

278

1.17

0.44

1.3

32.70

203.19

u/l

0.91

202

Dental caries 3

262

1.15

0.43

1.3

521.43

109.39

u/l

0.39

179

Disorders of the thyroid gland

336

1.15

0.43

1.2

1.3

87.17

257.14

u/l

0.58

242

Spontaneous abortion

1.31

0.43

1.0

1.4

59.45

433.06

u/l

0.57

Outcome of delivery

0.00

0.42

0.0

1.3

—

22.73

—

Any mental disorder

319

1.13

0.42

1.3

98.39

278.37

u/l

0.61

230

Symptoms and signs involving speech and voice

158

1.27

0.41

1.3

1.2

103.33

273.52

u/l

0.39

115

Melanocytic naevi of other and unspecified parts of face

0.00

0.41

0.0

1.1

—

2420.11

—

Eating disorders

0.00

0.41

0.0

1.1

—

2425.67

—

Excessive vomiting in pregnancy

0.00

0.41

0.0

1.5

—

2732.56

—

Other joint disorders

215

1.16

0.41

1.2

38.81

114.54

u/l

1.46

156

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.41

0.0

1.1

—

17.80

—

Suppurative and unspecified otitis media

101

1.32

0.40

1.7

1.3

74.44

119.03

u/l

—

Use of ropinirole

0.00

0.40

0.0

1.2

—

17.42

—

Malignant neoplasm of prostate

220

0.83

0.40

1.4

1.3

34.55

224.76

u/l

0.64

163

Fracture of shoulder and upper arm

177

1.24

0.40

1.6

1.2

60.73

267.62

u/l

0.60

125

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.43

0.39

1.0

1.4

22.20

955.42

u/l

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.39

0.0

1.2

—

16.57

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.39

0.0

1.4

—

1986.55

—

Unspecified/other endometriosis

0.00

0.39

0.0

1.5

—

30.62

—

Cervicobrachial syndrome

1.35

0.37

1.2

1.3

3651.43

450.65

u/l

—

Excessive attrition of teeth

0.77

0.37

1.1

1.2

38.87

155.55

u/l

—

Medicines for HER+ breast cancer

130

1.27

0.37

1.3

33.25

331.62

u/l

0.64

Open wound of forearm

1.35

0.37

1.4

1.1

120.20

21.56

u/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

314

1.13

0.36

1.2

1.3

113.20

272.56

u/l

0.48

223

Dental caries, including avohilmo

258

1.13

0.35

1.3

556.39

110.52

u/l

0.39

176

Dental caries 1

258

1.13

0.35

1.3

556.39

110.52

u/l

0.39

176

Other symptoms and signs involving cognitive functions and awareness

256

1.17

0.34

1.2

1.3

66.72

199.40

u/l

0.54

187

Leiomyoma of uterus

129

1.19

0.32

1.2

1.3

35.37

331.23

u/l

0.67

Basal cell carcinoma

301

1.14

0.32

1.2

1.3

118.34

265.25

u/l

0.39

217

Dental caries 3 and operation codes

281

1.11

0.31

1.3

511.05

102.47

u/l

0.40

195

Parodontitis

370

1.12

0.31

1.3

583.79

184.62

u/l

0.32

265

Parodontitis or operation codes

370

1.11

0.31

1.3

583.79

184.62

u/l

0.32

265

Hypothyroidism, other/unspecified

307

1.12

0.30

1.2

1.3

94.11

276.26

u/l

0.56

220

Alzheimer disease, including avohilmo

165

0.83

0.29

1.1

1.3

38.70

263.44

u/l

—

109

Headache

193

1.17

0.29

1.5

1.3

82.26

261.55

u/l

0.54

138

Primary open-angle glaucoma

190

0.82

0.28

1.3

1.2

30.82

219.23

u/l

0.60

133

Other disorders of veins

167

1.20

0.28

1.4

1.2

80.79

89.34

u/l

0.05

124

Gonarthrosis,primary

354

1.10

0.28

1.4

1.3

588.59

164.57

u/l

0.35

251

Anxiety disorders, excluding more controls

260

1.12

0.27

1.3

32.69

327.13

u/l

0.99

186

Coxibs

0.81

0.27

1.1

1.3

23.87

83.27

u/l

—

Psychiatric diseases

311

1.09

0.27

1.3

97.92

283.09

u/l

0.62

225

Hypothyroidism, strict autoimmune

229

1.13

0.26

1.3

104.73

210.46

u/l

0.27

170

Basal cell carcinoma, including avohilmo

303

1.12

0.26

1.2

1.3

118.34

262.93

u/l

0.39

219

Retinal breaks without detachment

0.68

0.26

1.8

1.2

44.80

476.06

u/l

—

Atopic dermatitis, strict definition

0.67

0.26

2.8

1.4

45.40

519.62

u/l

—

Noninflammatory disorders of female genital tract

0.79

0.25

1.3

1.4

4080.17

78.17

u/l

—

Chronic periodontitis, including avohilmo

371

1.10

0.24

1.3

597.58

184.15

u/l

0.32

266

Nontoxic multinodular goitre

1.25

0.24

1.1

1.3

33.43

364.48

u/l

—

Coxarthrosis, primary, with hip surgery

292

0.88

0.24

1.3

33.85

179.46

u/l

0.75

205

5-aminosalicylic acid

1.17

0.24

1.3

24.56

182.17

u/l

—

Other disorders of eyelid

247

1.13

0.23

1.1

1.3

94.61

69.71

u/l

0.19

178

Depression or dysthymia

237

0.90

0.23

1.3

1.2

147.80

365.91

u/l

0.48

165

Psoriasis

134

1.19

0.22

1.0

1.3

104.70

322.80

u/l

—

101

Dental caries 1 and operation codes

278

1.09

0.22

1.3

523.29

103.03

u/l

0.40

193

Benign paroxysmal vertigo

144

1.18

0.22

1.5

1.2

2143.68

275.42

u/l

0.40

100

Disorders of optic nerve, not elsewhere classified

0.00

0.21

0.0

1.0

—

14.60

—

Erythema intertrigo

0.00

0.21

0.0

1.0

—

14.80

—

Prurigo nodularis

0.00

0.21

0.0

1.0

—

3622.67

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.21

0.0

1.0

—

14.80

—

Dental caries 1, only avohilmo

268

1.09

0.21

1.3

558.39

106.72

u/l

0.40

184

Macular cyst

0.00

0.21

0.0

1.1

—

19.33

—

Convergent concomitant strabismus

0.00

0.21

0.0

1.0

—

3106.00

—

Vascular dementia (mixed)

0.00

0.21

0.0

1.1

—

18.88

—

Tuberculosis of other organs

0.00

0.21

0.0

1.0

—

16.75

—

Other deformities of toe(s)

0.00

0.21

0.0

1.4

—

339.13

—

Other obstructive and reflux uropathy

0.00

0.21

0.0

1.1

—

18.00

—

Persons encountering health services in circumstances related to reproduction

136

1.15

0.20

1.2

1.3

32.79

342.84

u/l

0.82

103

Circumscribed brain atrophy

0.00

0.20

0.0

1.1

—

16.67

—

Other and unspecified degenerative diseases of nervous system

0.00

0.20

0.0

1.0

—

17.56

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.20

0.0

1.4

—

3067.38

—

Alzheimer disease

149

0.86

0.19

1.1

1.2

36.67

288.82

u/l

—

Atrophic disorders of skin

1.18

0.19

2.8

1.3

38.33

735.53

u/l

—

Disorders of vitreous body

275

0.89

0.19

1.3

28.11

320.01

u/l

1.03

194

Mood disorders

349

0.92

0.19

1.3

49.41

283.77

u/l

1.02

243

Mood [affective] disorders

349

0.92

0.19

1.3

49.41

283.77

u/l

1.02

243

Disorders of vitreous body and globe

283

0.90

0.18

1.3

28.11

316.18

u/l

1.04

197

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.17

0.17

1.3

27.00

553.87

u/l

—

Extrapyramidal and movement disorders

216

0.88

0.17

1.3

43.92

371.90

u/l

0.89

156

Papulosquamous disorders

195

1.13

0.17

1.0

1.3

172.83

227.96

u/l

0.12

149

Female infertility, cervigal, vaginal, other or unspecified origin

1.16

0.16

1.0

1.4

77.63

75.00

u/l

—

Dental caries 3, only avohilmo

272

1.07

0.16

1.3

544.60

105.70

u/l

0.40

187

Hallux valgus (acquired)

110

0.86

0.16

2.1

1.3

42.13

70.88

u/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

295

0.92

0.15

1.3

141.50

287.16

u/l

0.38

210

Any dementia

179

1.10

0.15

1.0

1.3

35.53

241.01

u/l

0.59

121

Persons encountering health services for other counselling and medical advice, not elsewhere classified

355

1.06

0.15

1.2

1.3

41.69

180.16

u/l

0.90

249

Dental pulpitis 2

234

1.07

0.14

1.3

639.75

105.08

u/l

0.42

159

Gonarthrosis, primary, with knee surgery

301

0.92

0.14

1.3

1014.48

179.49

u/l

0.42

212

Exposure to other specified factors

321

1.08

0.14

1.2

1.3

1626.07

89.39

u/l

0.77

225

Superficial injury of head

1.18

0.14

1.2

1.3

478.33

70.83

u/l

—

Injuries to the wrist and hand

369

1.06

0.13

1.2

1.3

871.40

152.85

u/l

0.48

270

Other diseases of hard tissues of teeth

227

0.92

0.13

1.4

1.3

42.06

108.37

u/l

1.21

158

Pregnancy with abortive outcome

121

0.91

0.12

1.0

1.3

33.54

342.52

u/l

0.63

Artrosis, including avohilmo

275

1.06

0.11

1.3

33.61

210.89

u/l

0.91

195

Colonic or urogenital fistula

126

0.87

0.11

1.2

1.3

37.00

330.12

u/l

—

Organic, including symptomatic, mental disorders

243

1.07

0.11

1.1

1.3

39.12

329.87

u/l

0.87

172

malignant neoplasm of male genital organs

218

0.93

0.11

1.5

1.3

33.91

226.06

u/l

0.65

162

Mood disorders, excluding more controls

302

0.95

0.10

1.3

50.49

296.54

u/l

0.92

214

Disorders of skin appendages

198

0.91

0.10

1.6

1.2

39.40

244.94

u/l

—

150

Ventral hernia

115

1.13

0.10

1.5

1.3

457.00

293.92

u/l

—

Disorders of breast

145

0.89

0.10

1.1

1.3

18.50

295.60

u/l

—

102

Conjunctivitis

271

0.93

0.10

1.5

1.2

1003.62

89.67

u/l

0.50

197

Spondylosis

240

0.93

0.10

1.2

1.3

1461.39

217.79

u/l

0.41

170

Burns and corrosions of external body surface, specified by site

1.14

0.10

1.0

1.2

4348.00

26.53

u/l

—

Mucosal proctocolitis

1.11

0.09

1.8

1.4

23.80

717.57

u/l

—

Other sleep disorders

1.09

0.09

1.0

1.3

5090.00

37.47

u/l

—

Depression

326

0.95

0.09

1.3

51.45

296.23

u/l

0.99

228

Diseases of middle ear and mastoid

182

1.08

0.09

1.5

1.2

1496.13

112.39

u/l

0.45

131

Parodontitis and operation codes

371

1.05

0.09

1.4

1.3

680.61

184.26

u/l

0.34

266

Disorders of conjunctiva

310

0.95

0.09

1.5

1.3

1834.81

84.04

u/l

0.80

219

In situ neoplasms

194

1.08

0.09

1.1

1.2

77.47

221.56

u/l

0.38

129

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.90

0.09

1.2

1.3

29.33

86.17

u/l

0.48

Burns and corrosions

1.07

0.08

1.0

1.3

3626.17

29.03

u/l

—

Benign neoplasm: Transverse colon

1.03

0.08

1.8

1.2

37.83

609.55

u/l

—

Benign neoplasm: Skin of other and unspecified parts of face

1.03

0.08

1.5

1.3

32.00

600.67

u/l

—

Other disorders of patella

0.82

0.08

1.2

1.4

38.40

194.66

u/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.06

0.08

1.3

25.71

504.98

u/l

—

Ulcerative colitis (strict definition, require KELA)

1.04

0.08

1.3

25.71

495.73

u/l

—

Female infertility

1.07

0.07

1.0

1.4

77.63

75.00

u/l

—

Fissure and fistula of anal and rectal regions

1.12

0.07

1.2

37.00

374.60

u/l

—

IBD patients in KELA-register

1.07

0.07

1.3

26.56

500.53

u/l

—

Inflammatory bowel disease, strict (require KELA)

1.02

0.07

1.3

26.56

488.75

u/l

—

Selective serotonin reuptake inhibitors

316

0.97

0.06

1.3

1.2

45.62

298.59

u/l

1.00

220

Dementia

211

0.95

0.06

1.0

1.3

37.95

377.99

u/l

0.86

146

Coxarthrosis, primary

333

1.04

0.06

1.3

876.42

163.56

u/l

0.41

236

Myocardial infarction, with ST-elevation

121

0.91

0.06

1.5

1.2

54.20

326.07

u/l

—

Nontoxic goitre/thyroid nodule

139

1.08

0.05

1.2

313.00

273.71

u/l

—

Persons encountering health services in other circumstances, wide

359

1.03

0.05

1.2

1.3

483.13

178.38

u/l

0.29

252

Ovarian cyst

1.09

0.05

1.2

1.4

50.29

63.36

u/l

—

Acetic acid derivatives and related substances

1.06

0.05

1.1

1.3

1489.81

83.27

u/l

0.46

Primary coxarthrosis, bilateral

179

1.06

0.05

1.2

1980.38

232.49

u/l

0.41

122

Dental pulpitis 2, only avohilmo

243

1.03

0.04

1.3

638.75

106.85

u/l

0.42

166

Retinal detachments and breaks

199

1.06

0.04

1.2

1.3

118.60

402.05

u/l

0.62

143

Parodontitis or/and operation codes

204

0.96

0.04

1.1

1.3

1108.15

276.44

u/l

0.34

153

Alzheimer disease, excluding more controls

1.10

0.04

1.0

1.1

43.20

55.46

u/l

—

Anxiety (asthma-related co-morbidities)

157

1.05

0.04

1.2

29.53

280.62

u/l

0.73

116

Dental pulpitis 4, only avohilmo

342

1.02

0.04

1.1

1.3

489.28

189.32

u/l

0.30

240

Injuries to the shoulder and upper arm

387

0.97

0.03

1.4

1.3

45.89

259.40

u/l

1.06

272

Blepharochalasis

161

1.06

0.03

1.2

1.3

110.40

61.21

u/l

—

117

Diverticular disease of intestine

273

0.97

0.03

1.5

1.3

34.33

302.94

u/l

1.00

205

Dental pulpitis 1, only avohilmo

344

1.02

0.02

1.1

1.3

489.28

187.94

u/l

0.30

242

Dementia, including avohilmo

220

0.97

0.02

1.0

1.3

37.33

364.28

u/l

0.86

152

Any dementia, excluding more controls

175

1.03

0.01

1.0

1.2

36.75

425.68

u/l

0.81

122

Dental operations, only avohilmo

235

0.98

0.01

1.4

1.3

785.07

76.31

u/l

0.52

162

Use of memantine

142

1.04

0.01

1.2

43.11

70.50

u/l

—

Use of other anti-dementia drugs

142

1.04

0.01

1.2

43.11

70.50

u/l

—

Other extrapyramidal and movement disorders in other diseases

114

1.05

0.00

1.4

1.2

29.43

327.98

u/l

—

Disorders of vestibular function (Vertigo)

252

1.02

0.00

1.4

1.3

1300.51

202.41

u/l

0.40

177

Gingivitis and periodontal diseases

265

1.01

0.00

1.2

1.3

692.11

102.45

u/l

0.44

186

Diseases of external ear

162

0.99

0.00

1.2

1.3

42.36

272.47

u/l

0.63

114

Inflammatory diseases of female pelvic organs

142

1.01

0.00

1.2

1.3

42.19

304.18

u/l

0.62

Primary gonarthrosis, bilateral

276

1.01

0.00

1.3

1088.00

194.53

u/l

0.41

193

Other degenerative diseases of the nervous system

1.04

0.00

1.1

1.2

35.86

49.24

u/l

—

Complications of labour and delivery

104

1.02

0.00

1.2

1.3

47.04

367.74

u/l

0.60

Diseases of inner ear

296

0.99

0.00

1.4

1.3

1185.41

183.23

u/l

0.40

206

Anti-inflammatory and antirheumatic products, non-steroids

1.03

0.00

1.2

1.3

20.87

83.27

u/l

0.58

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

107

1.03

0.00

1.1

1.3

165.17

379.72

u/l

—

All anxiety disorders

170

0.99

0.00

1.2

1.3

29.53

292.36

u/l

0.84

124

Other superficial mycoses

0.00

0.0

1.0

—

15.40

—

Other maltreatment syndromes

0.00

0.0

1.0

—

13.00

—

Complications predominantly related to the puerperium

0.97

0.00

1.8

1.2

25.83

593.01

u/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.97

0.00

1.3

25.71

478.73

u/l

—

Benign neoplasm: Caecum

0.97

0.00

1.3

42.00

582.20

u/l

—

Crossbite

0.00

0.0

1.0

—

3620.67

—

Childhood allergy (age < 16)

0.00

0.0

1.6

—

29.20

—

Mumps

0.00

0.0

1.0

—

15.00

—

Parapsoriasis

0.00

0.0

1.0

—

15.00

—

Benign lipomatous neoplasm of other sites/unspecified

0.94

0.00

1.2

1.3

31.82

646.00

u/l

—

0.00

0.0

1.2

—

20.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS